BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16985142)

  • 1. Hysterosalpingography for assessing efficacy of Essure microinsert permanent birth control device.
    Wittmer MH; Famuyide AO; Creedon DJ; Hartman RP
    AJR Am J Roentgenol; 2006 Oct; 187(4):955-8. PubMed ID: 16985142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy after microinsert sterilization with tubal occlusion confirmed by hysterosalpingogram.
    Ory EM; Hines RS; Cleland WH; Rehberg JF
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):508-10. PubMed ID: 18239002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonography, CT, and MRI appearance of the Essure microinsert permanent birth control device.
    Wittmer MH; Brown DL; Hartman RP; Famuyide AO; Kawashima A; King BF
    AJR Am J Roentgenol; 2006 Oct; 187(4):959-64. PubMed ID: 16985143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necessity of hysterosalpingography after Essure microinsert placement for contraception.
    Lazarus E; Lourenco AP; Casper S; Allen RH
    AJR Am J Roentgenol; 2012 Jun; 198(6):1460-3. PubMed ID: 22623563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-step transvaginal three-dimensional hysterosalpingo-foam sonography (3D-HyFoSy) confirmation test for Essure® follow-up: a multicenter study.
    Zizolfi B; Lazzeri L; Franchini M; Di Spiezio Sardo A; Nappi C; Piccione E; Exacoustos C
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):134-141. PubMed ID: 28067009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Essure hysterosalpingography compliance in a clinic population.
    Shavell VI; Abdallah ME; Diamond MP; Kmak DC; Berman JM
    J Minim Invasive Gynecol; 2008; 15(4):431-4. PubMed ID: 18588851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality imaging of the Essure tubal occlusion device.
    Simpson WL; Beitia L
    Clin Radiol; 2012 Dec; 67(12):e112-7. PubMed ID: 22985750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Hysterosalpingo-Foam Sonography for Assessment of the Efficacy of Essure Hysteroscopic Sterilization.
    Rosič M; Žegura B; Vadnjal Đonlagić S
    J Ultrasound Med; 2018 Aug; 37(8):1929-1935. PubMed ID: 29344973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of three-dimensional ultrasound examination classification to check the position of the tubal sterilization microinsert.
    Legendre G; Gervaise A; Levaillant JM; Faivre E; Deffieux X; Fernandez H
    Fertil Steril; 2010 Dec; 94(7):2732-5. PubMed ID: 20451183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).
    Thiel J; Rattray D; Cher DJ
    J Minim Invasive Gynecol; 2014; 21(6):1055-60. PubMed ID: 24861649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges.
    Dreyer K; Hompes PG; Mijatovic V
    Reprod Biomed Online; 2015 Apr; 30(4):421-5. PubMed ID: 25682307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essure microinsert imaging: does abnormal shape on ultrasound predict complications on HSG?
    VanBuren WM; Suchet IB; Thiel JA; Karreman E
    Abdom Radiol (NY); 2016 Dec; 41(12):2350-2358. PubMed ID: 27022912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tubal patency after essure placement.
    Rodriguez AM; Kilic GS; Vu TP; Kuo YF; Breitkopf D; Snyder RR
    J Minim Invasive Gynecol; 2013; 20(4):468-72. PubMed ID: 23541247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast infusion sonography in the post-Essure setting.
    Connor V
    J Minim Invasive Gynecol; 2008; 15(1):56-61. PubMed ID: 18262145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorrect position of Essure microinserts 3 months after successful bilateral placement.
    Gerritse MB; Veersema S; Timmermans A; Brölmann HA
    Fertil Steril; 2009 Mar; 91(3):930.e1-5. PubMed ID: 18945426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of mechanical tubal occlusion devices and potential complications.
    Guelfguat M; Gruenberg TR; Dipoce J; Hochsztein JG
    Radiographics; 2012 Oct; 32(6):1659-73. PubMed ID: 23065163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubal perforation by Essure: three different clinical presentations.
    Langenveld J; Veersema S; Bongers MY; Koks CA
    Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
    Karthigasu KA; Garry R; Hart R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):365-7. PubMed ID: 16866803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast infusion sonography to assess microinsert placement and tubal occlusion after Essure.
    Connor VF
    Fertil Steril; 2006 Jun; 85(6):1791-3. PubMed ID: 16650420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative Factors that Predict the Successful Placement of Essure Microinserts.
    Arthuis CJ; Simon EG; Hébert T; Marret H
    J Minim Invasive Gynecol; 2017; 24(5):803-810. PubMed ID: 28390945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.